Lennox-Gastaut syndrome

·November 7, 2019

Study provides insights on the effects of cannabidiol on severe form of epilepsy

The effect cannabidiol has on Lennox-Gastaut syndrome may be explained by the drug-drug interaction between CBD and anti-seizure medication. Read More

Featured Neurology Open Neuroscience Articles

·November 7, 2018

Cannabis Compound CBD Beneficial for Children with Epilepsy

A new study reports a 39 to 46% reduction in seizures in children with Dravet syndrome and Lennox-Gastaut syndrome when given CBD based treatments. Read More

Featured Neurology

·June 25, 2018

Cannabis Derived Drug Could Be a Game Changer for Children with Severe Epilepsy

Researchers say a new cannabis derived drug, which is expected to receive full approval from the FDA this week, will be a vital intervention for children with Dravet Syndrome and Lennox-Gastaut syndrome. Read More

Featured Neurology

·May 17, 2018

Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

Researchers provide further evidence that the cannabis compound, CBD, is effective at reducing seizures in people with epilepsy. The new study reveals CBD significantly reduced seizures in people with Lennox-Gastaut syndrome. Previously, the researchers demonstrated CBD was effective at seizure control in Dravet syndrome. Read More

Featured Neurology

·January 26, 2018

Cannabidiol May Help Reduce Seizures For Those With Treatment Resistant Epilepsy

A new study in The Lancet reports coupling cannabidiol with other anti-epilepsy treatments can help reduce the number of seizures in those with Lennox-Gastaut syndrome, a treatment resistant form of epilepsy. Read More

Featured Neurology

·April 19, 2017

Cannabis Based Medicine May Cut Seizures in Half For Those With Hard to Treat Epilepsy

Cannabidiol could help cut seizures by half in children and adults with Lennox-Gastaut syndrome, an extremely severe form of epilepsy, researchers report. Read More